BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 35711912)

  • 1. StarGazer: A Hybrid Intelligence Platform for Drug Target Prioritization and Digital Drug Repositioning Using Streamlit.
    Lee C; Lin J; Prokop A; Gopalakrishnan V; Hanna RN; Papa E; Freeman A; Patel S; Yu W; Huhn M; Sheikh AS; Tan K; Sellman BR; Cohen T; Mangion J; Khan FM; Gusev Y; Shameer K
    Front Genet; 2022; 13():868015. PubMed ID: 35711912
    [TBL] [Abstract][Full Text] [Related]  

  • 2. COMO: a pipeline for multi-omics data integration in metabolic modeling and drug discovery.
    Bessell B; Loecker J; Zhao Z; Aghamiri SS; Mohanty S; Amin R; Helikar T; Puniya BL
    Brief Bioinform; 2023 Sep; 24(6):. PubMed ID: 37930022
    [TBL] [Abstract][Full Text] [Related]  

  • 3. integRATE: a desirability-based data integration framework for the prioritization of candidate genes across heterogeneous omics and its application to preterm birth.
    Eidem HR; Steenwyk JL; Wisecaver JH; Capra JA; Abbot P; Rokas A
    BMC Med Genomics; 2018 Nov; 11(1):107. PubMed ID: 30453955
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Computational Study of Drugs by Integrating Omics Data with Kernel Methods.
    Wang YC; Deng N; Chen S; Wang Y
    Mol Inform; 2013 Dec; 32(11-12):930-41. PubMed ID: 27481139
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PS4DR: a multimodal workflow for identification and prioritization of drugs based on pathway signatures.
    Emon MA; Domingo-Fernández D; Hoyt CT; Hofmann-Apitius M
    BMC Bioinformatics; 2020 Jun; 21(1):231. PubMed ID: 32503412
    [TBL] [Abstract][Full Text] [Related]  

  • 6. DrugNet: network-based drug-disease prioritization by integrating heterogeneous data.
    Martínez V; Navarro C; Cano C; Fajardo W; Blanco A
    Artif Intell Med; 2015 Jan; 63(1):41-9. PubMed ID: 25704113
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rethinking Drug Repositioning and Development with Artificial Intelligence, Machine Learning, and Omics.
    Koromina M; Pandi MT; Patrinos GP
    OMICS; 2019 Nov; 23(11):539-548. PubMed ID: 31651216
    [TBL] [Abstract][Full Text] [Related]  

  • 8. GuiltyTargets: Prioritization of Novel Therapeutic Targets With Network Representation Learning.
    Muslu O; Hoyt CT; Lacerda M; Hofmann-Apitius M; Frohlich H
    IEEE/ACM Trans Comput Biol Bioinform; 2022; 19(1):491-500. PubMed ID: 32750869
    [TBL] [Abstract][Full Text] [Related]  

  • 9. DeepDRK: a deep learning framework for drug repurposing through kernel-based multi-omics integration.
    Wang Y; Yang Y; Chen S; Wang J
    Brief Bioinform; 2021 Sep; 22(5):. PubMed ID: 33822890
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A multi-modal data harmonisation approach for discovery of COVID-19 drug targets.
    Chen T; Philip M; Lê Cao KA; Tyagi S
    Brief Bioinform; 2021 Nov; 22(6):. PubMed ID: 34036326
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Network-based drug discovery by integrating systems biology and computational technologies.
    Leung EL; Cao ZW; Jiang ZH; Zhou H; Liu L
    Brief Bioinform; 2013 Jul; 14(4):491-505. PubMed ID: 22877768
    [TBL] [Abstract][Full Text] [Related]  

  • 12. AlzGPS: a genome-wide positioning systems platform to catalyze multi-omics for Alzheimer's drug discovery.
    Zhou Y; Fang J; Bekris LM; Kim YH; Pieper AA; Leverenz JB; Cummings J; Cheng F
    Alzheimers Res Ther; 2021 Jan; 13(1):24. PubMed ID: 33441136
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Integrating multiple single-cell multi-omics samples with Smmit.
    Wan C; Ji Z
    bioRxiv; 2023 Apr; ():. PubMed ID: 37066420
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A primer on applying AI synergistically with domain expertise to oncology.
    Kim J; Kusko R; Zeskind B; Zhang J; Escalante-Chong R
    Biochim Biophys Acta Rev Cancer; 2021 Aug; 1876(1):188548. PubMed ID: 33901609
    [TBL] [Abstract][Full Text] [Related]  

  • 15. SUBATOMIC: a SUbgraph BAsed mulTi-OMIcs clustering framework to analyze integrated multi-edge networks.
    Loers JU; Vermeirssen V
    BMC Bioinformatics; 2022 Sep; 23(1):363. PubMed ID: 36064320
    [TBL] [Abstract][Full Text] [Related]  

  • 16. SerotoninAI: Serotonergic System Focused, Artificial Intelligence-Based Application for Drug Discovery.
    Łapińska N; Pacławski A; Szlęk J; Mendyk A
    J Chem Inf Model; 2024 Apr; 64(7):2150-2157. PubMed ID: 38289046
    [TBL] [Abstract][Full Text] [Related]  

  • 17. iDrug: Integration of drug repositioning and drug-target prediction via cross-network embedding.
    Chen H; Cheng F; Li J
    PLoS Comput Biol; 2020 Jul; 16(7):e1008040. PubMed ID: 32667925
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An omics perspective on drug target discovery platforms.
    Paananen J; Fortino V
    Brief Bioinform; 2020 Dec; 21(6):1937-1953. PubMed ID: 31774113
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clustering and variable selection evaluation of 13 unsupervised methods for multi-omics data integration.
    Pierre-Jean M; Deleuze JF; Le Floch E; Mauger F
    Brief Bioinform; 2020 Dec; 21(6):2011-2030. PubMed ID: 31792509
    [TBL] [Abstract][Full Text] [Related]  

  • 20. DDAPRED: a computational method for predicting drug repositioning using regularized logistic matrix factorization.
    Wang X; Yan R
    J Mol Model; 2020 Feb; 26(3):60. PubMed ID: 32062701
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.